Severe viral infections and primary immunodeficiencies.
Lesia K Dropulic, Jeffrey I Cohen
https://pubmed.ncbi.nlm.nih.gov/21960712/Actively Recruiting
Led by National Institute of Allergy and Infectious Diseases (NIAID) · Updated on 2026-08-04
600
Participants Needed
1
Research Sites
N/A
Total Duration
Viral infections often cause common illnesses like colds, sore throats, chicken pox, and the flu. While most people recover quickly, some individuals experience severe, persistent, or hard-to-treat viral infections possibly due to immune system defects. Researchers are studying these severe viral infections in patients without known immunodeficiency to understand immune and genetic factors that may contribute to their condition. Participants include children and adults with diagnosed severe or unusual viral infections caused by viruses such as herpesviruses, papillomaviruses, adenoviruses, polyomaviruses, or influenza. Relatives of affected individuals may also join to help study hereditary immune defects. Participants receive the best available treatment for their infections at the NIH Clinical Center, where blood samples and other tests like skin biopsies are done to evaluate their immune systems over time. During the study, participants undergo evaluations as outpatients or inpatients at the Clinical Center. Researchers monitor infection responses to treatment and collect blood and tissue samples intermittently. Follow-up visits occur during and after illness to track infection progress and immune system changes. The main goal is to identify immune or genetic defects that lead to severe viral infections, with participant involvement lasting up to 10 years.
CONDITIONS
The Natural History of Severe Viral Infections and Characterization of Immune Defects in Patients Without Known Immunocompromise
K
Kayla D Morgan
J
Jessica R Durkee-Shock, M.D.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
National Institute of Allergy and Infectious Diseases (NIAID)
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 screening visit
Duration - Varies by participant
Participants receive the best available therapy for their viral infection at the NIH Clinical Center while researchers monitor their immune system through blood samples and skin biopsies.
Outpatient or inpatient visits as needed
Duration - Up to 10 years
Researchers conduct follow-up visits during and after illness to observe infection progress and response to treatment.
Periodic follow-up visits
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Lesia K Dropulic, Jeffrey I Cohen
https://pubmed.ncbi.nlm.nih.gov/21960712/Lesia K Dropulic, Mir A Ali, Amanda K Ombrello...
https://pubmed.ncbi.nlm.nih.gov/27025823/Emily M Mace, Amy P Hsu, Linda Monaco-Shawver...
https://pubmed.ncbi.nlm.nih.gov/23365458/National Institute of Allergy and Infectious Diseases (NIAID)
Lead Sponsor